Literature DB >> 17030034

Pro-apoptotic low-density lipoprotein subfractions in type II diabetes.

Chao-yuh Yang1, Hsin-Hung Chen, Max T Huang, Joe L Raya, Jun-Hai Yang, Chu-Huang Chen, John W Gaubatz, Henry J Pownall, Addison A Taylor, Christie M Ballantyne, Floor A Jenniskens, Charles V Smith.   

Abstract

OBJECTIVE: To test the hypothesis that differences in subfractions of circulating lipoproteins between diabetic and non-diabetic subjects exist and might contribute to the increased risk for atherosclerosis in type II diabetics. METHODS AND
RESULTS: LDL isolated from diabetic (D) and control subjects (N) were separated by FPLC into five subfractions (L1-L5). The fractional distributions of N- and D-LDL were not different, but the most strongly retained subfractions of D-LDL (D-L5) were markedly more pro-apoptotic to bovine aortic endothelial cells in vitro than were the other subfractions in D- or N-LDL. D-L5 induced time- and concentration-dependent apoptosis that was inhibited by z-VAD-fmk. The most electronegative D-LDL subfractions contained substantial amounts of apoproteins AI, E and CIII, higher concentrations of non-esterified fatty acids and LpPLA2, and lower trinitrobenzenesulfonic acid (TNBSA) reactivities. Electronegative subfractions of D-LDL exhibited longer lag times and lower net increases in absorbance at 234 nm with Cu-catalyzed oxidation in vitro.
CONCLUSIONS: The toxicities of electronegative subfractions of LDL from diabetic subjects to endothelial cells in vitro may be pivotal to vascular complications of diabetes in vivo, but the specific molecular alterations responsible for the toxicities of these subfractions of diabetic LDL are not known.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030034     DOI: 10.1016/j.atherosclerosis.2006.08.059

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Biochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.

Authors:  Ju-Yi Hsieh; Chiz-Tzung Chang; Max T Huang; Chia-Ming Chang; Chia-Ying Chen; Ming-Yi Shen; Hsin-Yi Liao; Guei-Jane Wang; Chu-Huang Chen; Chao-Jung Chen; Chao-Yuh Yang
Journal:  Anal Chem       Date:  2013-11-13       Impact factor: 6.986

2.  Proteomic analysis of electronegative low-density lipoprotein.

Authors:  Cristina Bancells; Francesc Canals; Sònia Benítez; Nuria Colomé; Josep Julve; Jordi Ordóñez-Llanos; José Luis Sánchez-Quesada
Journal:  J Lipid Res       Date:  2010-08-10       Impact factor: 5.922

3.  Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein.

Authors:  Liang-Yin Ke; David A Engler; Jonathan Lu; Risë K Matsunami; Hua-Chen Chan; Guei-Jane Wang; Chao-Yuh Yang; Jan-Gowth Chang; Chu-Huang Chen
Journal:  Pure Appl Chem       Date:  2011       Impact factor: 2.453

Review 4.  The underlying chemistry of electronegative LDL's atherogenicity.

Authors:  Liang-Yin Ke; Nicole Stancel; Henry Bair; Chu-Huang Chen
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

5.  Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation.

Authors:  Hua-Chen Chan; Liang-Yin Ke; Chih-Sheng Chu; An-Sheng Lee; Ming-Yi Shen; Miguel A Cruz; Jing-Fang Hsu; Kai-Hung Cheng; Hsiu-Chuan Bonnie Chan; Jonathan Lu; Wen-Ter Lai; Tatsuya Sawamura; Sheng-Hsiung Sheu; Jeng-Hsien Yen; Chu-Huang Chen
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

Review 6.  Effects of Lipids and Lipoproteins on Mesenchymal Stem Cells Used in Cardiac Tissue Regeneration.

Authors:  Yi-Hsiung Lin; Lin Kang; Wen-Han Feng; Tsung-Lin Cheng; Wei-Chung Tsai; Hsuan-Ti Huang; Hsiang-Chun Lee; Chung-Hwan Chen
Journal:  Int J Mol Sci       Date:  2020-07-05       Impact factor: 5.923

Review 7.  Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies.

Authors:  Der-Yuan Chen; Tatsuya Sawamura; Richard A F Dixon; José Luis Sánchez-Quesada; Chu-Huang Chen
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

Review 8.  Electronegative LDL: a circulating modified LDL with a role in inflammation.

Authors:  Montserrat Estruch; José Luis Sánchez-Quesada; Jordi Ordóñez Llanos; Sònia Benítez
Journal:  Mediators Inflamm       Date:  2013-08-22       Impact factor: 4.711

9.  Range of L5 LDL levels in healthy adults and L5's predictive power in patients with hyperlipidemia or coronary artery disease.

Authors:  Chih-Sheng Chu; Hua-Chen Chan; Ming-Hsien Tsai; Nicole Stancel; Hsiang-Chun Lee; Kai-Hung Cheng; Yi-Ching Tung; Hsiu-Chuan Chan; Chung-Ya Wang; Shyi-Jang Shin; Wen-Ter Lai; Chao-Yuh Yang; Richard A Dixon; Chu-Huang Chen; Liang-Yin Ke
Journal:  Sci Rep       Date:  2018-08-08       Impact factor: 4.379

10.  Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis.

Authors:  Chiz-Tzung Chang; Guei-Jane Wang; Chin-Chi Kuo; Ju-Yi Hsieh; An-Sean Lee; Chia-Ming Chang; Chun-Cheng Wang; Ming-Yi Shen; Chiu-Ching Huang; Tatsuya Sawamura; Chao-Yuh Yang; Nicole Stancel; Chu-Huang Chen
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.